Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42,049 | -$37,161 | -$34,272 | -$33,543 |
| Dep. & Amort. | $104 | $104 | $104 | $104 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,517 | $4,667 | $0 | $14,297 |
| Change in WC | -$1,872 | $841 | -$1,606 | -$8,542 |
| Other Non-Cash | -$1,075 | -$1,321 | $5,211 | -$2,713 |
| Operating Cash Flow | -$40,375 | -$32,870 | -$30,563 | -$30,397 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$14,780 | -$100,730 | -$122,638 | -$58,475 |
| Inv. Sales/Matur. | $56,083 | $116,020 | $208,246 | $55,105 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $41,303 | $15,290 | $85,608 | -$3,370 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $138 | $0 |
| Stock Repurch. | -$11,426 | -$14,093 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $121 | $0 | -$485 | $0 |
| Financing Cash Flow | -$11,305 | -$14,093 | -$347 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10,377 | -$31,673 | $54,698 | -$33,767 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $87,721 | $119,394 | $64,696 | $98,463 |
| End Cash | $77,344 | $87,721 | $119,394 | $64,696 |
| Free Cash Flow | -$40,375 | -$32,870 | -$30,563 | -$30,397 |